Nurse Practitioner, Family · Douglas, GA
NPI
1154862894
Since 2017
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
4
Medicare group memberships
Hospitals
0
Hospital affiliations
1003 Shirley Ave
Douglas, GA, 31533
Phone (912) 389-4586
Groups this clinician bills Medicare through
Medicare paid, 2024
$1,327
60 services
Medicare patients, 2024
19
Average age 62
Drug cost, 2024
$2.1M
1,304 prescriptions
Company payments, 2025
$47.11
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Regina A Stone was code 36415 (venipuncture blood collection), 27 times for 17 patients. In total Regina A Stone billed 60 services in 5 codes, and Medicare paid $1,327.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-03-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 27 | 17 | $3.92 | $106 |
| 99213 Office E&M - Established | Office | 27 | 19 | $38.94 | $1,051 |
By year: 2022 $2,753 for 104 services; 2023 $1,219 for 48 services; 2024 $1,327 for 60 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 27 | 17 | $3.92 | $106 |
Medicare prescription drug claims, 2024
In 2024, the drug Regina A Stone prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 195 prescriptions and refills. In total Regina A Stone wrote 1,304 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 195 | 195 | 36 | $765K |
| Tivicay Dolutegravir Sodium | 157 | 157 | 20 | $332K |
| Descovy Emtricitabine/Tenofov Alafenam | 65 | 67 | Under 11 | $142K |
| Dovato Dolutegravir Sodium/Lamivudine | 64 | 64 | 11 | $192K |
| Gabapentin Generic | 53 | 53 | Under 11 | $655 |
| Ritonavir Generic | 47 | 47 | Under 11 | $2,919 |
| Atorvastatin Calcium Generic | 42 | 54 | 12 | $134 |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 39 | 39 | Under 11 | $166K |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 38 | 38 | Under 11 | $136K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 36 | 36 | Under 11 | $122K |
| Amlodipine Besylate Generic | 35 | 35 | Under 11 | $68.65 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 34 | 34 | Under 11 | $772 |
| Pifeltro Doravirine | 31 | 31 | Under 11 | $53K |
| Abacavir Abacavir Sulfate | 30 | 30 | Under 11 | $6,754 |
| Acyclovir Generic | 28 | 30 | Under 11 | $128 |
Brand drugs: 713 claims; generic drugs: 591 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Regina A Stone $47.11 ($47.11 in general payments such as food, travel and fees) from 1 company. The largest payer was Gilead Sciences, Inc. with $47.11.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 1 | $47.11 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.